Basic definitions, theoretical considerations, and practical aspects of routine therapeutic drug monitoring are discussed, with emphasis on the desirability of measuring the pharmacodynamic effects of a drug rather than its plasma concentrations. The advantages and problems of this approach are reviewed for a number of specific drugs and drug classes: digitalis, beta-blockers, antihypertensives, and antiarrhythmic agents.